Study of the antitumour effects and the modulation of immune response by histamine in breast cancer.

Melisa B NicoudHelena A SterleNoelia A MassariMónica A Táquez DelgadoKarina FormosoMaría V Herrero DuclouxDiego Martinel LamasGraciela A CremaschiVanina A Medina

Published in: British journal of cancer (2019)

Histamine plays a complex role and stands out as a promising drug for TNBC treatment, which deserves to be tested in clinical settings. HDC expression level is associated with clinicopathological characteristics, suggesting a prognostic value in breast cancer.

Keyphrases

immune response
poor prognosis
dendritic cells
binding protein
drug induced